..
..
"Shijiazhuang Yiling Pharmaceutical, which produces the government-endorsed herbal treatment Lianhua Qingwen, has added 11 per cent over the same period"https://t.co/wjuseeHugi
— Primrose Riordan (@primroseriordan) December 14, 2022
..
Investors bet on greed and fear as COVID grip loosens in #China [ https://t.co/Crq8lEsUMQ ] The panic over spreading infections has fired up #Stocks of cough medicines, flu drugs and antigen test kit makers.#Shijiazhuang Yiling Pharmaceutical Co Lt https://t.co/8FrTSzdqRT
— Tian_A1 (@Tian_A1) December 12, 2022
..
Chinese drug producer Yiling Pharmaceutical based in #Shijiazhuang has boosted production in response to the booming demand of the company's #TCM Lianhua Qingwen, which has been recommended for the treatment of #COVID19 by Chinese medical authorities. https://t.co/0SXGhMfSC0
— Bridge Consulting (@BridgeBeijing) November 23, 2022
..